产品中心

产品货号

产品名称

规格

销售价

会员价

货期

产地

订购

CG67

Recombinant Human Guanidinoacetate N-methyltransferase/GAMT

10ug

760

684

现货

国产

CG67

Recombinant Human Guanidinoacetate N-methyltransferase/GAMT

50ug

2280

2052

现货

国产

CG67

Recombinant Human Guanidinoacetate N-methyltransferase/GAMT

500ug

12320

11088

现货

国产

CG67

Recombinant Human Guanidinoacetate N-methyltransferase/GAMT

1mg

17600

15840

现货

国产

  • 产品简介
  • 使用说明
  • 相关产品
  • 参考文献
  • 购买咨询
  • Catalog# CG67
    Source E.coli
    Description Recombinant Human Guanidinoacetate N-methyltransferase/GAMT is produced with our E. coli expression system. The target protein is expressed with sequence (Met1-Gly236) of Human GAMT fused with a 6His tag at the N-terminus and C-terminus.
    Names Guanidinoacetate N-methyltransferase, GAMT, PIG2,TP53I2
    Accession # Q14353
    Formulation Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl,1mM DTT,pH 8.0
    Shipping The product is shipped on dry ice/ice packs.
    Storage Store at < -20°C, stable for 6 months after receipt.
    Please minimize freeze-thaw cycles.
    Purity Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.
    Endotoxin Less than 0.1 ng/µg (1 IEU/µg).
    Amino Acid Sequence
    MGSSHHHHHHSSGLVPRGSHMSAPSATPIFAPGENCSPAWGAAPAAYDAADTHLRILGKPVMERW ETPYMHALAAAASSKGGRVLEVGFGMAIAASKVQEAPIDEHWIIECNDGVFQRLRDWAPRQTHKV IPLKGLWEDVAPTLPDGHFDGILYDTYPLSEETWHTHQFNFIKNHAFRLLKPGGVLTYCNLTSWG ELMKSKYSDITIMFEETQVPALLEAGFRRENIRTEVMALVPPADCRYYAFPQMITPLVTKGLEHH HHHH*
    Background GAMT is a methyltransferase which belongs to the class I-like SAM-binding methyltransferase superfamily. It contains one RMT2 (arginine N-methyltransferase 2-like) domain and is expressed in liver. GAMT converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Defects in GAMT are the cause of guanidinoacetate methyltransferase deficiency, which is an autosomal recessive disorder characterized by developmental delay/regression, mental retardation, severe disturbance of expressive and cognitive speech, intractable seizures and movement disturbances, severe depletion of creatine/phosphocreatine in the brain, and accumulation of guanidinoacetic acid in brain and body fluids.